Sangamo Surges After Inking Gene Therapy Deal With Biogen

(Bloomberg) -- Biogen Inc. and small-cap drug developer Sangamo Therapeutics Inc. entered a partnership to develop gene therapies for diseases attacking the brain and central nervous system, includ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.